Trials / Unknown
UnknownNCT05401370
Role of Methylene Blue in Parotid Surgery
Role of Methylene Blue Dye in Identification of Facial Nerve in Parotid Surgery
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 20 (estimated)
- Sponsor
- Assiut University · Academic / Other
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
usefulness of the methylene blue staining for identification of facial nerve in parotid gland surgery
Detailed description
The specific surgical morbidity remains significant in parotid gland surgery. In addition to temporary facial weakness and permanent facial nerve injury, postparotidectomy depression and Frey's syndrome (gustatory sweating) are specific for this type of surgery. To reduce the surgical morbidity, several modifications of parotidectomy have been implemented but postsurgical complications remain especially facial nerve injury . To overcome this difficulty, an identification method might be used such as preoperative intravital staining of the gland with methylene blue (MB). Although MB staining is not designed to be used as a sole technique, it can be combined with other techniques such as identification of the anatomic landmarks. MB staining is simple, inexpensive, and not time consuming technique.It is an indirect facial nerve identification technique, because there is no nerve handling,thus decreasing iatrogenic nerve impairment.After injection of the parotid gland with MB dye, fine white nerve fibers can be observed . Tumors in the parotid gland are also easily seen because they are not stained and will be visible in the surgical field.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Methylene blue dye | For MB group, the staining of the glandular tissue will be obtained with 3-4 mL of 1% MB that will be introduced into the gland via the salivary duct several minutes before the surgery.The trans-oral catheterization of the Stensen's duct will be performed and the solution will be injected via intravenous cannula.The glandular tissue will turn dark blue. |
Timeline
- Start date
- 2022-06-01
- Primary completion
- 2023-10-01
- Completion
- 2023-12-01
- First posted
- 2022-06-02
- Last updated
- 2022-06-02
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT05401370. Inclusion in this directory is not an endorsement.